Patents by Inventor Denis Labrecque

Denis Labrecque has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030221497
    Abstract: A scanner assembly for dovetail inspection of the wheels of a turbine rotor includes a series of circumferentially pivotally connected links: a motor link, transmission links, an encoder link, an adjustable link, free links and a base link mounting a transducer. The motor link mounts a motor for driving rollers on the transmission links and rotating the scanner assembly about the rotor shaft. The encoder link mounts an encoder for determining the circumferential position of the transducer about the shaft. The adjustable link enables the assembly to be tightened or loosened about the rotor shaft. The free links and base link complete the circular scanner assembly about the shaft. A single scan for a full 360° investigates the plurality of hooks on the side of the wheel opposite the transducer.
    Type: Application
    Filed: May 31, 2002
    Publication date: December 4, 2003
    Inventors: Thomas Francis Murphy, Robert Martin Roney, Robert L'Heureux, Denis Labrecque
  • Patent number: 6630488
    Abstract: The present invention is directed towards novel compounds that are effective inhibitors of integrins, particularly &agr;IIb&bgr;3 or &agr;v integrins such as &agr;v&bgr;3 and &agr;v&bgr;5. One embodiment of the present invention comprises a compound of formula (I) or formula (II) or a pharmaceutically acceptable salt, solvate, or metabolic precursor thereof. R1, R2, R3, and R4 are defined herein.
    Type: Grant
    Filed: March 20, 2001
    Date of Patent: October 7, 2003
    Assignee: Biochem Pharma, Inc.
    Inventors: Serge Lamothe, Boulos Zacharie, Giorgio Attardo, Denis Labrecque, Marc Courchesne, Guy Falardeau, Rabindra Rej, Shaun Abbott
  • Publication number: 20020137947
    Abstract: A novel compound which inhibits certain integrins, particularly &agr;v integrins. Additionally, the novel compound may be used in a method of treating tumors or cancer which comprises administering a pharmaceutically effective amount of the compound to a patient. Additionally, the novel compound may be used in a method of inhibiting angiogensis. Finally, a method of producing the novel compound is disclosed.
    Type: Application
    Filed: January 16, 2002
    Publication date: September 26, 2002
    Applicant: BioChem Pharma Inc.
    Inventors: Denis Labrecque, Serge Lamothe, Marc Courchesne, Laval Chan, Giorgio Attardo, Karen Meerovitch
  • Patent number: 6274620
    Abstract: The present invention comprises compounds that are effective inhibitors of integrins, particularly &agr;v&bgr;3 and &agr;v&bgr;5 integrins. Particularly, the compounds are of formula I and pharmaceutically acceptable salts thereof wherein X,Y1 W, R1 to R5, A and B are defined according to the disclosure herein.
    Type: Grant
    Filed: June 7, 2000
    Date of Patent: August 14, 2001
    Assignee: BioChem Pharma Inc.
    Inventors: Denis Labrecque, Giorgio Attardo, Monica Bubenik, Laval Chan, Sylvie Charron, Réal Denis, Guy Falardeau, Serge Lamothe, Patrice Préville, Boulos Zacharie